Cargando…

Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats

OBJECTIVES: The aim of this study was to evaluate Gd retention in the deep cerebellar nuclei (DCN) of linear gadolinium-based contrast agents (GBCAs) compared with a macrocyclic contrast agent. MATERIALS AND METHODS: The brain tissue retention of Gd of 3 linear GBCAs (gadobenate dimeglumine, gadopen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robert, Philippe, Violas, Xavier, Grand, Sylvie, Lehericy, Stéphane, Idée, Jean-Marc, Ballet, Sébastien, Corot, Claire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747982/ https://www.ncbi.nlm.nih.gov/pubmed/26606549 http://dx.doi.org/10.1097/RLI.0000000000000241

Ejemplares similares

T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents
por: Robert, Philippe, et al.
Publicado: (2015)

Analytical Interference in Serum Iron Determination Reveals Iron Versus Gadolinium Transmetallation With Linear Gadolinium-Based Contrast Agents
por: Fretellier, Nathalie, et al.
Publicado: (2014)

Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats
por: Rasschaert, Marlène, et al.
Publicado: (2018)

Gadolinium-bound Contrast Agents: No Evidence-based Data to Support a Relationship Between Structure and Hypersensitivity Reactions
por: Idee, Jean-Marc, et al.
Publicado: (2012)

Small Brain Lesion Enhancement and Gadolinium Deposition in the Rat Brain: Comparison Between Gadopiclenol and Gadobenate Dimeglumine
por: Violas, Xavier, et al.
Publicado: (2022)

Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents
por: Strzeminska, Izabela, et al.
Publicado: (2020)

Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats
por: Rasschaert, Marlène, et al.
Publicado: (2017)

Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
por: Bussi, Simona, et al.
Publicado: (2020)

Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents
por: Ringler, Michael D., et al.
Publicado: (2021)

Gadolinium Retention in the Brain of Mother and Pup Mouse: Effect of Pregnancy and Repeated Administration of Gadolinium‐Based Contrast Agents
por: Yao, Xiang, et al.
Publicado: (2022)

Gadolinium deposition in the brain of dogs after multiple intravenous administrations of linear gadolinium based contrast agents
por: Richter, Henning, et al.
Publicado: (2020)

Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats
por: Fretellier, Nathalie, et al.
Publicado: (2019)

Retention of Gadolinium in Brain Parenchyma: Pathways for Speciation, Access, and Distribution. A Critical Review
por: Rasschaert, Marlène, et al.
Publicado: (2020)

Physicochemical and Pharmacokinetic Profiles of Gadopiclenol: A New Macrocyclic Gadolinium Chelate With High T1 Relaxivity
por: Robic, Caroline, et al.
Publicado: (2019)

The New Restrictions on the Use of Linear Gadolinium-based Contrast Agents in Japan
por: Kanda, Tomonori
Publicado: (2018)

Gadolinium contrast agents: Over exposure?
por: Biederman, Robert W, et al.
Publicado: (2016)

Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents
por: Lohrke, Jessica, et al.
Publicado: (2017)

Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats
por: Bussi, Simona, et al.
Publicado: (2017)

Gadolinium retention and clearance after administration of macrocyclic magnetic resonance contrast agents to rats
por: Bussi, Simona, et al.
Publicado: (2019)

Gadolinium-DTPA: A New Contrast Agent
por: Niendorf, H. P.
Publicado: (1988)

The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review
por: Olchowy, Cyprian, et al.
Publicado: (2017)

Gadolinium Complexes as Contrast Agent for Cellular NMR Spectroscopy
por: Sakol, Nat, et al.
Publicado: (2020)

Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents
por: Jeong, Sang Young, et al.
Publicado: (2010)

Immediate reaction to gadolinium based contrast agent with fatal outcome()()()
por: Behzadi, Ashkan Heshmatzadeh, et al.
Publicado: (2018)

Gadolinium-Based Contrast Agents Hypersensitivity: A Case Series
por: Nucera, Eleonora, et al.
Publicado: (2021)

Gadolinium-based contrast agents in neurofibromatosis type 1 (Review)
por: Năstase, Florentina, et al.
Publicado: (2021)

Recent Advances in Gadolinium Based Contrast Agents for Bioimaging Applications
por: Fatima, Atiya, et al.
Publicado: (2021)

Hypersensitivity to Gadolinium-Based Contrast Media
por: Gracia Bara, M. Teresa, et al.
Publicado: (2022)

Fatal Allergic Reaction to Gadolinium Contrast
por: Chalise, Som N, et al.
Publicado: (2023)

Gadolinium Retention after Contrast-Enhanced Magnetic Resonance Imaging: A Narratative Review
por: Al-Muhanna, Afnan Fahd
Publicado: (2022)

Thermal Excitation of Gadolinium-Based Contrast Agents Using Spin Resonance
por: Dinger, Steven C., et al.
Publicado: (2016)

Acute respiratory distress syndrome after the use of gadolinium contrast agent
por: Kerget, Bugra, et al.
Publicado: (2018)

Effect of different doses of gadolinium contrast agent on clinical outcomes in MS
por: Ackermans, Nathalie, et al.
Publicado: (2019)

Investigating the Impact of Gadolinium-Based Contrast Agents on the Corrected QT Interval
por: Gress, Kyle L, et al.
Publicado: (2020)

PEG-modified gadolinium nanoparticles as contrast agents for in vivo micro-CT
por: Cruje, Charmainne, et al.
Publicado: (2021)

Formation of gadolinium–ferritin from clinical magnetic resonance contrast agents
por: Neburkova, Jitka, et al.
Publicado: (2020)

Gadolinium as a contrast agent for infusion sialograms in patients with iodine allergy
por: Sabotin, Ryan P., et al.
Publicado: (2023)

Geometrical confinement of gadolinium-based contrast agents in nanoporous particles enhances T(1) contrast
por: Ananta, Jeyarama S., et al.
Publicado: (2010)

Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats
por: Frenzel, Thomas, et al.
Publicado: (2017)

Impact of brain tumors and radiotherapy on the presence of gadolinium in the brain after repeated administration of gadolinium-based contrast agents: an experimental study in rats
por: Jost, Gregor, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tt8qr2g1abkgs8f080dl05votu